Efficacy of a Novel Contact Pathway Inhibitor, Ir-CPI, on in vitro Clotting Induced by PCI Catheter Segment

Jonathan Douxfils, Damien Gheldof, Sandrine Derochette, Joel Tassignon, Céline Meinguet, Michel Guyaux, Jean-Michel Dogne, Edmond Godfroid

Research output: Contribution in Book/Catalog/Report/Conference proceedingConference contribution

6 Downloads (Pure)
Original languageEnglish
Title of host publicationResearch and practice in thrombosis and haemostasis
Subtitle of host publicationAbstracts of the XXVI Congress of the International Society on Thrombosis and Haemostasis, July 8–13, 2017
Pages1044-1045
Number of pages2
Volume1
Publication statusPublished - 2017
EventXXVI Congress of the International Society on Thrombosis and Haemostasis - Berlin, Germany
Duration: 8 Jul 201713 Jul 2017

Conference

ConferenceXXVI Congress of the International Society on Thrombosis and Haemostasis
CountryGermany
CityBerlin
Period8/07/1713/07/17

Cite this

Douxfils, J., Gheldof, D., Derochette, S., Tassignon, J., Meinguet, C., Guyaux, M., ... Godfroid, E. (2017). Efficacy of a Novel Contact Pathway Inhibitor, Ir-CPI, on in vitro Clotting Induced by PCI Catheter Segment. In Research and practice in thrombosis and haemostasis: Abstracts of the XXVI Congress of the International Society on Thrombosis and Haemostasis, July 8–13, 2017 (Vol. 1, pp. 1044-1045)